SCHEMBL15840242

SCHEMBL15840242

c1ccc(-c2cc(-c3ccc(-n4c5ccccc5c5ccc6c(c54)-c4ccccc4C64c5ccccc5-c5ccccc54)cc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.35
KMT2A Q03164 7/20 0.35
MEN1 O00255 6/20 0.35
ALDH1A1 P00352 5/20 0.35
HPGD P15428 5/20 0.35
NTSR1 P30989 1/20 0.35
KDM4E B2RXH2 4/20 0.32
LMNA P02545 2/20 0.32
GLA P06280 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
MAPK1 P28482 1/20 0.32
ATM Q13315 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31
NPSR1 Q6W5P4 3/20 0.31
CYP2C19 P33261 3/20 0.31
CYP1A2 P05177 2/20 0.31
CYP2C9 P11712 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25121711 1.00 MAPT (0.35) MAPTKMT2AMEN1ALDH1A1HPGD
SCHEMBL25966131 0.99 MAPT (0.34) MAPTKMT2AMEN1ALDH1A1HPGD
SCHEMBL25966205 0.94 MAPT (0.35) MAPTKMT2AMEN1ALDH1A1HPGD
SCHEMBL15832292 0.94 KDM4E (0.34) KMT2AKDM4EL3MBTL1ATMDUSP3
SCHEMBL25965684 0.93 KDM4E (0.33) KMT2AKDM4EL3MBTL1ATMDUSP3
SCHEMBL25121524 0.93 KDM4E (0.33) KMT2AKDM4EL3MBTL1ATMDUSP3
SCHEMBL19524804 0.92 MEN1 (0.33) MAPTKMT2AMEN1ALDH1A1HPGD
SCHEMBL25121578 0.92 MEN1 (0.32) MAPTKMT2AMEN1ALDH1A1HPGD
SCHEMBL25966057 0.91
SCHEMBL24078670 0.91 MEN1 (0.32) MAPTKMT2AMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230108986-A1 ELECTRONIC DEVICE MERCK PATENT GMBH (DE) 2023-04-06 US disclosed
US-10227528-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2019-03-12 US disclosed
EP-2935276-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2017-11-01 EP disclosed
US-20150337197-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2015-11-26 US disclosed
US-20150337197-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2015-11-26 US disclosed
WO-2014094963-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2014-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10227528-B2 Materials for organic electroluminescent devices OR10J3, EPCAM, L1CAM MAPT 874/4885KMT2A 1945/4885MEN1 1650/4885
US-20150337197-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES OR10J3, EML4, L1CAM MAPT 941/4885KMT2A 2434/4885MEN1 1571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.